Loading clinical trials...
Loading clinical trials...
Use of a New Blood Test to Identify Response to Targeted Treatment in Patients With EGFR Mutated Lung Cancer. Evaluation in a Multicenter Study
Conditions
Locations
1
Denmark
Aarhus University Hospital
Aarhus, DK, Denmark
Start Date
September 1, 2014
Primary Completion Date
December 10, 2018
Completion Date
June 10, 2020
Last Updated
November 12, 2019
NCT07143110
NCT06885697
NCT04577599
NCT06974604
NCT07035587
NCT04631770
Lead Sponsor
Aarhus University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions